<DOC>
	<DOCNO>NCT01555788</DOCNO>
	<brief_summary>The primary purpose pilot study test artificial pancreas system use intra-peritoneal ( IP ) route insulin delivery type 1 diabetic patient .</brief_summary>
	<brief_title>DiaPort Closed-Loop Artificial Pancreas</brief_title>
	<detailed_description>During study , investigator would like evaluate intra-peritoneal insulin delivery potential breakthrough method deliver insulin within artificial pancreas system . The intent exploit rapid action achieve IP insulin compensate meal management basal insulin need . Patients come two closed-loop admission 24 hour . The first closed-loop perform use subcutaneous route , whereas second one perform use intra-peritoneale route .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<mesh_term>Pancreatin</mesh_term>
	<criteria>Patient must age 18 ( inclusive ) 65 year old Patient must clinically diagnose Type 1 diabetes mellitus least one year Patient must identify present indication DiaPort® system , i.e . show poor glucose control Sc insulin delivery show sustained HbA1C level &gt; 8 % and/or high blood glucose variability include recurrent hypoglycemic event . Patient eligible study he/she DiaPort implant . Patient must demonstrate proper mental status cognition study Patient must affiliate beneficiary social medical insurance Patient sign informed consent form prior study entry Unwilling perform repeat glucose check , consume standardized meal , and/or take insulin instruct Evidence cardiovascular event previous 6 month , non stabilize retinopathy , clinically significant screen laboratory abnormality Pregnancy , breast feeding , intention become pregnant Medical condition require use acetaminophencontaining medication withheld study admission . Patient actively enrol another clinical trial part study within 30 day whose annual study income 4 500€ Persons deprive freedom , adult protect law vulnerable person</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>type 1 diabetes ,</keyword>
	<keyword>diaport ,</keyword>
	<keyword>artificial pancreas ,</keyword>
	<keyword>zone mpc algorithm ,</keyword>
	<keyword>ap system ,</keyword>
	<keyword>intraperitoneal insulin</keyword>
</DOC>